All News

Challenges in the therapeutic options for the Interstitial Lung Disease:
When to start?
Immunosuppressant, wich one?
Antifibrotic?
How to evaluate effectiveness?
#EULAR2019 Dr. Grutters (Netherlands) https://t.co/lPsKa1wwxE
Dr.Martínez MtzReuma ( View Tweet)

Prof Mariette: the level of RF does not always correlate with the level of cryoglobulins. However on the converse if you are treating cryo vasculitis you should treat to reduction of RF titre. Resurgence of RF often signifies relapse. #eular2019 @RheumNow
Alberta Hoi tuna0sashimi ( View Tweet)

Interesting study examining novel way to quantify inflammation when CRP is not typically useful in psoriatic disease. Biomarkers such as IL8, lipocalin 2, calprotectin, IL22 & beta defensin 2 are useful in a spectrum of pts with skin v entheseal v joints inv #eular2019 @RheumNow https://t.co/UHPjnrJuks
Alberta Hoi tuna0sashimi ( View Tweet)

@RheumNow #EULAR2019 #op0140 #giacta cumulative steroid dose was lower in patients asigned to weekly tcz initially. Flares where resolved with tcz alone in 15 days.
Cecilia Pisoni Drapisoni ( View Tweet)

Erosions sometime seen in normal people and people who are acpa positive and arthralgia OP0133 @RheumNow #EULAR2019 https://t.co/xuod6RBGiI
Sharath Kumar arthritisdr ( View Tweet)

Plenty happening in ANCA-assoc vasculitis - just a taste of recent insights into induction therapy: pulse methylpred does not improve survival but increases sepsis and diabetes, MMF similar induction rates to CYC but more relapses #EULAR2019 SP0044 from Raashid Luqmani @RheumNow https://t.co/3VhxaAPZm9 https://t.co/BdhbLSzNC1
David Liew drdavidliew ( View Tweet)

Kinesiophobia
Fear that exercise might cause a flare of RA/pain
Hopefully, rheumatologists don’t add to this in how we handle Qs on exercise. My bias is multidisciplinary care, working with interested physios & exercise physiologists matters
#eular2019
Dr Irwin Lim _connectedcare ( View Tweet)

Is RA getting milder? Swedish registry of 6559 new DMARD naive #RA pts followed since 1991 shows signif decline in SJC TJC CRP ESR, increase in global assessment and shorter time to Dx. #EULAR2019 THU0063 https://t.co/LMeJVpg5uF
Dr. John Cush RheumNow ( View Tweet)

The role of uric acid in #FattyLiver #Gout #MetabolicSyndrome - Miguel Lanaspa #EULAR2019 https://t.co/zD2VplHUMt
Dr.Martínez MtzReuma ( View Tweet)

Excellent summary of various benefits of #aerobic & #strength training #exercise at various timepoints
via @GeorgeMetsios #EULAR2019
Good to know when prescribing exercise & guiding patients with rheumatic musculoskeletal conditions 👍🏼 https://t.co/qw0GeEj8Xj
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)

Current @eular_org guidelines for management of ANCA vasculitis #EULAR2019 https://t.co/3Yh0uKYuKx
Valentina Emperiale vemperiale ( View Tweet)

Treating Fatigue in RA. I’m guilty of not addressing 1,2&5 well #EULAR2019 https://t.co/NBvVr4aF1P
Dr Irwin Lim _connectedcare ( View Tweet)

In anti-CCP positive patients with arthralgias but no clinical synovitis, the more Power Doppler signal, the more likely future inflamm arthritis #EULAR2019 THU0072 Paul Emery’s Leeds group @RheumNow https://t.co/QsQ2BV0qKC
David Liew drdavidliew ( View Tweet)

#PhysicalActivity has some evidence for improving rheumatic disease activity & #inflammation
⬇️ESR
⬇️IL-17a
⬇️IL-18
⬇️TNF alpha receptors
⬆️IL-6
via @NoreleeK #EULAR2019
#exercise #arthritis https://t.co/RtARGnbQta
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)

In this week's issue for #EULAR2019: Upadacitinib as monotherapy in patients with active #rheumatoidarthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study https://t.co/hyAKuBPVtJ https://t.co/xSnHZFZtKo
Links:
The Lancet TheLancet ( View Tweet)

Do you really believe that @_connectedcare ? https://t.co/QmGFTOLCyK
Dr Philip Robinson philipcrobinson ( View Tweet)

We’re getting closer to something we can use.....RT @sylba2308: New targets in #osteoarthritis #EULAR2019 https://t.co/sBEkeJuPza
Dr Irwin Lim _connectedcare ( View Tweet)

Contemporary epidemiology of gout in the UK population.. #EULAR2019 @KeeleUniversity #Gout https://t.co/lcNz84InBL
Dr.Martínez MtzReuma ( View Tweet)

Interesting politic that may exist between the 2 authoritative bodies on axial vs peripheral SpA #eular2019 https://t.co/Ksc4C3iELj
Alberta Hoi tuna0sashimi ( View Tweet)

I worry about really long term use and atypical fractures Irwin, pretty serious consideration after 7 years of BP therapy. https://t.co/RUQeLbpZjm
Dr Philip Robinson philipcrobinson ( View Tweet)